Young laboratory woman with testtubes

Recent News

May 2018

Francesca Cavallaro joins aTen Therapeutics from the University of Edinburgh to undertake a 3-month work-based MSc project investigating the target of our novel antibody.

May 2018

aTen Therapeutics attends the Scottish Life Sciences awards in Glasgow.

aTen Therapeutics

An innovative biotechnology company.

We are developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases. These novel approaches give aTen Therapeutics the potential to develop powerful new treatments to extend and improve lives.

Tensinomab product logo

Our novel antibody with huge therapeutic potential.

© aTen Therapeutics 2018. All rights reserved